MA37425B1 - Bispecific anti-baff-anti-il-17 antibodies - Google Patents
Bispecific anti-baff-anti-il-17 antibodiesInfo
- Publication number
- MA37425B1 MA37425B1 MA37425A MA37425A MA37425B1 MA 37425 B1 MA37425 B1 MA 37425B1 MA 37425 A MA37425 A MA 37425A MA 37425 A MA37425 A MA 37425A MA 37425 B1 MA37425 B1 MA 37425B1
- Authority
- MA
- Morocco
- Prior art keywords
- baff
- antibodies
- bispecific antibodies
- bispecific
- ssp
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
Abstract
L'invention concerne des anticorps bispécifiques qui lient de manière spécifique le facteur d'activation des lymphocytes b de la famille du tnf (baff) et l'interleukine-17a (il-17) et sont caractérisés en qu'ils présentent une haute affinité et de fortes propriétés de neutralisation envers à la fois baff et il-17. Les anticorps bispécifiques de l'invention sont censés être utiles dans le traitement de la néphropathie lupique (nl), le lupus érythémateux disséminé (led), l'arthrite rhumatoïde (ar), le psoriasis (ps), la spondylarthrite ankylosante (sa), le rhumatisme psoriasique (rp), le syndrome de sjögren primaire (ssp) ou le myélome multiple (mm).The present invention relates to bispecific antibodies that specifically bind the activation factor of tnf (baff) family b-lymphocytes and interleukin-17a (il-17) and are characterized by having high affinity and strong neutralizing properties towards both baff and il-17. The bispecific antibodies of the invention are believed to be useful in the treatment of lupus nephropathy (nl), systemic lupus erythematosus (led), rheumatoid arthritis (ar), psoriasis (ps), ankylosing spondylitis (AS) , psoriatic arthritis (rp), primary sjögren's syndrome (ssp) or multiple myeloma (mm).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261636302P | 2012-04-20 | 2012-04-20 | |
PCT/US2013/036677 WO2013158577A1 (en) | 2012-04-20 | 2013-04-16 | Anti-baff-anti-il-17 bispecific antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
MA37425A1 MA37425A1 (en) | 2017-10-31 |
MA37425B1 true MA37425B1 (en) | 2018-12-31 |
Family
ID=58044249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA37425A MA37425B1 (en) | 2012-04-20 | 2013-04-16 | Bispecific anti-baff-anti-il-17 antibodies |
Country Status (2)
Country | Link |
---|---|
MA (1) | MA37425B1 (en) |
UA (1) | UA113080C2 (en) |
-
2013
- 2013-04-16 MA MA37425A patent/MA37425B1/en unknown
- 2013-04-16 UA UAA201411015A patent/UA113080C2/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA37425A1 (en) | 2017-10-31 |
UA113080C2 (en) | 2016-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12014502333A1 (en) | Anti-baff-anti-il-17 bispecific antibodies | |
PH12015501994A1 (en) | Antibodies that bind il-23 | |
EA201591478A1 (en) | BISPECIFIC ANTIBODIES AGAINST TNF and IL-17 | |
CU24597B1 (en) | HETERODIMERIC BIESPECIFIC ANTIBODIES THAT BIND CD3 AND CD20 | |
EA201300418A1 (en) | ANTIBODIES TO THE HUMAN TWEAK AND VARIANTS OF THEIR APPLICATION | |
WO2013011076A3 (en) | Tnf -alpha antigen- binding proteins with increased fcrn binding | |
WO2014114651A9 (en) | Tnf-alpha antigen-binding proteins | |
MX365690B (en) | Anti-hla-b*27 antibodies and uses thereof. | |
EA201892790A1 (en) | APPLICATION OF 2-SUBSTITUTED INDAZOLS FOR THE TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASES | |
MA35740B1 (en) | Compositions and methods for antibodies targeting the factor p | |
MX2015007034A (en) | Anti-blood dendritic cell antigen 2 antibodies and uses thereof. | |
EA201290360A1 (en) | HUMANIZED ANTIBODIES AGAINST HUMAN IL-22RA | |
MA37946A1 (en) | Treatment of rheumatoid arthritis | |
WO2009000929A3 (en) | Composition and method for treatment of autoimmune disease | |
RU2016129167A (en) | SPECIFIC ANTIBODIES TO ALPHA-ENOLASE AND METHOD OF APPLICATION FOR IMMUNE DISEASES | |
MA43088B1 (en) | Anti-il-17c antibodies | |
MA37425A1 (en) | Bispecific anti-baff-anti-il-17 antibodies | |
TN2014000413A1 (en) | Anti-baff-anti-il-17 bispecific antibodies | |
EA201890741A1 (en) | BISPECIFIC ANTIBODIES AGAINST CGRP / IL-23 AND THEIR APPLICATIONS | |
TH1401006266A (en) | ANTI-BAFF-ANTI-IL-17 Bspecific Antibody | |
MA39559A1 (en) | Glucocorticoid Induced Tumor Necrosis Factor Receptor Antibody (gitr) and their Uses | |
MA35686B1 (en) | Anti-ox40 Antibodies and Methods of Use | |
UA99527C2 (en) | Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof | |
UY30505A1 (en) | PHENYLINDOLS AS ANTAGONISTS OF PROSTAGLANDINA D2 RECEPTOR |